For centuries, governments have tried to encourage innovation by offering inventors something valuable in return: ownership. The earliest forms of state-recognized intellectual property—like patents—were meant to reward people for coming…

A Patent’s Value Means Little Without the Means to Defend ItValuing a patent isn’t simple—methods like the cost, market, and income approaches are commonly used—but even a high-value patent may…

In the ever-evolving world of pharmaceutical patent law, a recent Federal Circuit decision offers some clarity on when a generic drug label might be considered to induce patent infringement. The…

In a closely watched decision, the Federal Circuit just made it clear: simply applying machine learning to a new domain—without improving the ML itself—won’t get you a patent.In Recentive Analytics,…

In a move that’s sending ripples through the patent world, Acting USPTO Director Coke Stewart has officially rescinded the June 2022 Vidal Memorandum. That memo had put significant limits on…

In Maquet Cardiovascular LLC v. Abiomed Inc., the Federal Circuit issued a significant ruling that reshapes how prosecution history disclaimer applies across related patents. The decision vacated a district court judgment…

For inventors and patent practitioners, securing a patent has always been a challenge—but when it comes to overcoming a § 101 rejection, the odds are stacked against applicants. The latest…

On February 11, 2025, the U.S. District Court for the District of Delaware delivered a landmark decision in Thomson Reuters Enterprise Centre GmbH v. Ross Intelligence Inc., ruling that the…

The Federal Circuit has issued a significant ruling in US Synthetic Corp. v. Int’l Trade Comm’n, reversing the ITC’s controversial decision that had invalidated composition of matter claims as abstract…